A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is
InternatIonal journal of BIomedIcal scIence
Donor cell leukaemia (DcL) is a rare complication of allogenic hematopoietic cell transplantation (Hct). We report the case of a female patient with acute promyelocytic leukaemia (APL), FAb type M3, who developed acute myeloid leukaemia (AML) type M5 of donor origin 17 years after allogenic bone marrow trans-plantation (bMt) from her HLA-matched sister. Morphology and immunophenotyping showed differences with the initial leukaemia, and short tandem repeat (STR) analysis confirmed donor-typefatcat:p7wwhjjdn5byfnqtxtraws4uli